Cargando…

Reporting of abstracts in studies that used routinely collected data for exploring drug treatment effects: a cross-sectional survey

BACKGROUND: In recent years, studies that used routinely collected data (RCD), such as electronic medical records and administrative claims, for exploring drug treatment effects, including effectiveness and safety, have been increasingly published. Abstracts of such studies represent a highly attend...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Mei, Wang, Wen, Wang, Mingqi, He, Qiao, Li, Ling, Li, Guowei, He, Lin, Zou, Kang, Sun, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742367/
https://www.ncbi.nlm.nih.gov/pubmed/34996370
http://dx.doi.org/10.1186/s12874-021-01482-9
_version_ 1784629697484685312
author Liu, Mei
Wang, Wen
Wang, Mingqi
He, Qiao
Li, Ling
Li, Guowei
He, Lin
Zou, Kang
Sun, Xin
author_facet Liu, Mei
Wang, Wen
Wang, Mingqi
He, Qiao
Li, Ling
Li, Guowei
He, Lin
Zou, Kang
Sun, Xin
author_sort Liu, Mei
collection PubMed
description BACKGROUND: In recent years, studies that used routinely collected data (RCD), such as electronic medical records and administrative claims, for exploring drug treatment effects, including effectiveness and safety, have been increasingly published. Abstracts of such studies represent a highly attended source for busy clinicians or policy-makers, and are important for indexing by literature database. If less clearly presented, they may mislead decisions or indexing. We thus conducted a cross-sectional survey to systematically examine how the abstracts of such studies were reported. METHODS: We searched PubMed to identify all observational studies published in 2018 that used RCD for assessing drug treatment effects. Teams of methods-trained collected data from eligible studies using pilot-tested, standardized forms that were developed and expanded from “The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology” (RECORD-PE) statement. We used descriptive analyses to examine how authors reported data source, study design, data analysis, and interpretation of findings. RESULTS: A total of 222 studies were included, of which 118 (53.2%) reported type of database used, 17 (7.7%) clearly reported database linkage, and 140 (63.1%) reported coverage of data source. Only 44 (19.8%) studies stated a predefined hypothesis, 127 (57.2%) reported study design, 140 (63.1%) reported statistical models used, 142 (77.6%) reported adjusted estimates, 33 (14.9%) mentioned sensitivity analyses, and 39 (17.6%) made a strong claim about treatment effect. Studies published in top 5 general medicine journals were more likely to report the name of data source (94.7% vs. 67.0%) and study design (100% vs. 53.2%) than those in other journals. CONCLUSIONS: The under-reporting of key methodological features in abstracts of RCD studies was common, which would substantially compromise the indexing of this type of literature and prevent the effective use of study findings. Substantial efforts to improve the reporting of abstracts in these studies are highly warranted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-021-01482-9.
format Online
Article
Text
id pubmed-8742367
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87423672022-01-10 Reporting of abstracts in studies that used routinely collected data for exploring drug treatment effects: a cross-sectional survey Liu, Mei Wang, Wen Wang, Mingqi He, Qiao Li, Ling Li, Guowei He, Lin Zou, Kang Sun, Xin BMC Med Res Methodol Research BACKGROUND: In recent years, studies that used routinely collected data (RCD), such as electronic medical records and administrative claims, for exploring drug treatment effects, including effectiveness and safety, have been increasingly published. Abstracts of such studies represent a highly attended source for busy clinicians or policy-makers, and are important for indexing by literature database. If less clearly presented, they may mislead decisions or indexing. We thus conducted a cross-sectional survey to systematically examine how the abstracts of such studies were reported. METHODS: We searched PubMed to identify all observational studies published in 2018 that used RCD for assessing drug treatment effects. Teams of methods-trained collected data from eligible studies using pilot-tested, standardized forms that were developed and expanded from “The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology” (RECORD-PE) statement. We used descriptive analyses to examine how authors reported data source, study design, data analysis, and interpretation of findings. RESULTS: A total of 222 studies were included, of which 118 (53.2%) reported type of database used, 17 (7.7%) clearly reported database linkage, and 140 (63.1%) reported coverage of data source. Only 44 (19.8%) studies stated a predefined hypothesis, 127 (57.2%) reported study design, 140 (63.1%) reported statistical models used, 142 (77.6%) reported adjusted estimates, 33 (14.9%) mentioned sensitivity analyses, and 39 (17.6%) made a strong claim about treatment effect. Studies published in top 5 general medicine journals were more likely to report the name of data source (94.7% vs. 67.0%) and study design (100% vs. 53.2%) than those in other journals. CONCLUSIONS: The under-reporting of key methodological features in abstracts of RCD studies was common, which would substantially compromise the indexing of this type of literature and prevent the effective use of study findings. Substantial efforts to improve the reporting of abstracts in these studies are highly warranted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-021-01482-9. BioMed Central 2022-01-07 /pmc/articles/PMC8742367/ /pubmed/34996370 http://dx.doi.org/10.1186/s12874-021-01482-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Mei
Wang, Wen
Wang, Mingqi
He, Qiao
Li, Ling
Li, Guowei
He, Lin
Zou, Kang
Sun, Xin
Reporting of abstracts in studies that used routinely collected data for exploring drug treatment effects: a cross-sectional survey
title Reporting of abstracts in studies that used routinely collected data for exploring drug treatment effects: a cross-sectional survey
title_full Reporting of abstracts in studies that used routinely collected data for exploring drug treatment effects: a cross-sectional survey
title_fullStr Reporting of abstracts in studies that used routinely collected data for exploring drug treatment effects: a cross-sectional survey
title_full_unstemmed Reporting of abstracts in studies that used routinely collected data for exploring drug treatment effects: a cross-sectional survey
title_short Reporting of abstracts in studies that used routinely collected data for exploring drug treatment effects: a cross-sectional survey
title_sort reporting of abstracts in studies that used routinely collected data for exploring drug treatment effects: a cross-sectional survey
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742367/
https://www.ncbi.nlm.nih.gov/pubmed/34996370
http://dx.doi.org/10.1186/s12874-021-01482-9
work_keys_str_mv AT liumei reportingofabstractsinstudiesthatusedroutinelycollecteddataforexploringdrugtreatmenteffectsacrosssectionalsurvey
AT wangwen reportingofabstractsinstudiesthatusedroutinelycollecteddataforexploringdrugtreatmenteffectsacrosssectionalsurvey
AT wangmingqi reportingofabstractsinstudiesthatusedroutinelycollecteddataforexploringdrugtreatmenteffectsacrosssectionalsurvey
AT heqiao reportingofabstractsinstudiesthatusedroutinelycollecteddataforexploringdrugtreatmenteffectsacrosssectionalsurvey
AT liling reportingofabstractsinstudiesthatusedroutinelycollecteddataforexploringdrugtreatmenteffectsacrosssectionalsurvey
AT liguowei reportingofabstractsinstudiesthatusedroutinelycollecteddataforexploringdrugtreatmenteffectsacrosssectionalsurvey
AT helin reportingofabstractsinstudiesthatusedroutinelycollecteddataforexploringdrugtreatmenteffectsacrosssectionalsurvey
AT zoukang reportingofabstractsinstudiesthatusedroutinelycollecteddataforexploringdrugtreatmenteffectsacrosssectionalsurvey
AT sunxin reportingofabstractsinstudiesthatusedroutinelycollecteddataforexploringdrugtreatmenteffectsacrosssectionalsurvey